ES2150848A1 - Set of methyloxy naphthyl substituted heterocyclics consists of therapeutic product countering eg. inflammation and cardio vascular diseases - Google Patents
Set of methyloxy naphthyl substituted heterocyclics consists of therapeutic product countering eg. inflammation and cardio vascular diseasesInfo
- Publication number
- ES2150848A1 ES2150848A1 ES009800791A ES9800791A ES2150848A1 ES 2150848 A1 ES2150848 A1 ES 2150848A1 ES 009800791 A ES009800791 A ES 009800791A ES 9800791 A ES9800791 A ES 9800791A ES 2150848 A1 ES2150848 A1 ES 2150848A1
- Authority
- ES
- Spain
- Prior art keywords
- methyloxy
- countering
- inflammation
- naphthyl substituted
- vascular diseases
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Abstract
The set of methyloxy naphthyl substituted heterocyclics comprises therapeutic products countering leucotriene attack. Each product contains a sulphur and a nitrogen atom with methyloxy naphthyl substitution, and pharmaceutically acceptable salts and solvates. The products are effective against inflammation, allergies and cardio vascular illnesses.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES9800791A ES2150848B1 (en) | 1998-04-15 | 1998-04-15 | HETEROCICLES METILOXINAFTIL SUBSTITUTED WITH ANTAGONIST ACTION OF LEUCOTRIENOS. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES9800791A ES2150848B1 (en) | 1998-04-15 | 1998-04-15 | HETEROCICLES METILOXINAFTIL SUBSTITUTED WITH ANTAGONIST ACTION OF LEUCOTRIENOS. |
Publications (2)
Publication Number | Publication Date |
---|---|
ES2150848A1 true ES2150848A1 (en) | 2000-12-01 |
ES2150848B1 ES2150848B1 (en) | 2001-07-01 |
Family
ID=8303461
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES9800791A Expired - Fee Related ES2150848B1 (en) | 1998-04-15 | 1998-04-15 | HETEROCICLES METILOXINAFTIL SUBSTITUTED WITH ANTAGONIST ACTION OF LEUCOTRIENOS. |
Country Status (1)
Country | Link |
---|---|
ES (1) | ES2150848B1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003104178A1 (en) * | 2002-06-07 | 2003-12-18 | Cortical Pty Ltd | Napththalene derivatives which inhibit the cytokine or biological activity of macrophage migration inhibitory factor (mif) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2032018T3 (en) * | 1987-07-31 | 1993-01-01 | American Home Products Corporation | PROCEDURE FOR THE PREPARATION OF NAFTILPROPIONIC ACID DERIVATIVES. |
ES2103181A1 (en) * | 1994-08-01 | 1997-08-16 | Menarini Lab | Naphthalene amides having leukotriene-antagonistic action |
-
1998
- 1998-04-15 ES ES9800791A patent/ES2150848B1/en not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2032018T3 (en) * | 1987-07-31 | 1993-01-01 | American Home Products Corporation | PROCEDURE FOR THE PREPARATION OF NAFTILPROPIONIC ACID DERIVATIVES. |
ES2103181A1 (en) * | 1994-08-01 | 1997-08-16 | Menarini Lab | Naphthalene amides having leukotriene-antagonistic action |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003104178A1 (en) * | 2002-06-07 | 2003-12-18 | Cortical Pty Ltd | Napththalene derivatives which inhibit the cytokine or biological activity of macrophage migration inhibitory factor (mif) |
GB2405146A (en) * | 2002-06-07 | 2005-02-23 | Cortical Pty Ltd | Napthalene derivatives which inhibit the cytokine or biological activity of macrophage migration inhibitory factor (MIF) |
Also Published As
Publication number | Publication date |
---|---|
ES2150848B1 (en) | 2001-07-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IT8422397A0 (en) | AROMATIC ESTERS AND AMIDES, THEIR PREPARATION AND THEIR USE AS MEDICAMENTS. | |
BR9306421A (en) | New n-aryl and n-heteroarylurea derivatives as acylcoenzyme a inhibitors: cholesterol acyltransferase (acat) | |
HK1047575A1 (en) | Indanyl-substituted benzole carbonamide, method for the production of the same, use thereof as a medicament and pharmaceutical preparations containingthe same. | |
RS50485B (en) | Therapeutic combinations comprising amlodipin and atorvastatin | |
WO1998016507A3 (en) | New heterocyclylmethyl-substituted pyrazol derivates and their use for treating cardiovascular diseases | |
IL127714A0 (en) | Use of topiramate or derivatives thereof for the manufacture of a medicament for the treatment of manic depressive bipolar disorders | |
DE69117868T2 (en) | SPRAYING TARGET AND THEIR PRODUCTION | |
ITRM920412A1 (en) | HETEROPROSTANOIDS, PROCEDURE FOR THEIR PREPARATION AND THERAPEUTIC USE. | |
IS1812B (en) | Therapeutic compounds, pharmaceutically acceptable salts and compositions containing the compounds, together with their use | |
EP0888776A4 (en) | A product of heat treatment of uronic acid, food, drink or drug including the product | |
ITMI920256A0 (en) | DIETARY AND/OR PHARMACEUTICAL COMPOSITIONS BASED ON FREEZE-DRIED LACTIC BACTERIA, THEIR PREPARATION AND USE | |
NO934282D0 (en) | Calcium, trace metal, vitamin D and drug therapy combinations | |
HUP0200386A3 (en) | Nitroxyderivatives having antiinflammatory, analgesic and antithrombotic activity and pharmaceutical compositions containing them and their use | |
EP0719791A3 (en) | Medicaments for the treatment of restenosis and arterial sclerosis | |
HU913137D0 (en) | 2-amino-4-carboxamido-pirimidine derivatives, their production and medical use | |
EE03663B1 (en) | Method of preventing breast cancer, pharmaceutical preparation and product, and use of the active ingredient | |
HK1018211A1 (en) | Pharmaceutical combination preparation of an inhibitor of the sodium/dydrogen exchanger and a medicament for the treatment of cardiovascular diseases. | |
AU3366899A (en) | Novel hiv integrase inhibitors and hiv therapy based on drug combinations including integrase inhibitors | |
NO962752D0 (en) | Use of 2,3-diaryl-1-benzopyran derivatives in the manufacture of a medicament for the treatment and prevention of bone loss and osteoporosis | |
NO305286B1 (en) | Quinoxaline compounds, pharmaceutical preparations comprising them, and their use in the manufacture of medicaments | |
NO990335D0 (en) | Arylic cycloalkanecarboxyl esters, their use, pharmaceutical compositions and preparation | |
HUP9901376A3 (en) | 1-methylcarbapenem derivatives, their use, production thereof and medicaments containing the same | |
ES2150848A1 (en) | Set of methyloxy naphthyl substituted heterocyclics consists of therapeutic product countering eg. inflammation and cardio vascular diseases | |
ZA977606B (en) | Antimicrobial medical devices and methods of production and use. | |
AU1604592A (en) | New 2-amino-5-cyano-1,4-dihydropyridines, processes for their preparation and their use in medicaments |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EC2A | Search report published |
Date of ref document: 20001201 Kind code of ref document: A1 Effective date: 20001201 |
|
FD1A | Patent lapsed |
Effective date: 20060417 |